Health

KFSH Advances Precision Surgery Through In-House 3D Printing Program

RIYADH, Saudi Arabia, April 25, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) is redefining surgical…

1 month ago

HeroUp Claims Evaluated: Investigating the Supplement Facts About Hero Up Capsules for Hardero Male Enhancement Support

Lakeland, FL, April 25, 2026 (GLOBE NEWSWIRE) -- This content contains affiliate links. If a purchase is made through these…

1 month ago

Quad ED Under Investigation: Safe Clinician-Prescribed ED Medication Using Sildenafil, Tadalafil, Vardenafil and Apomorphine for Men

Newark, DE, April 25, 2026 (GLOBE NEWSWIRE) -- This content contains affiliate links. If you purchase through these links, a…

1 month ago

HealthRX Blood Support Claims Evaluated: The Health RX Blood Pressure Optimizer Formula Under Investigation

New York, NY, April 25, 2026 (GLOBE NEWSWIRE) -- This article is an informational overview based on provided materials for…

1 month ago

Alpha Labs Male Enhancement Gummies Claims Evaluated: The AlphaLabs ED Gummy for Men Under Investigation

Tampa, FL, April 24, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through these…

1 month ago

Performance Lab Under Investigation: Premium-Grade Nutritional Supplements with Research-Backed Ingredients That Work

Royal Leamington Spa, United Kingdom, April 24, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is…

1 month ago

Park Dental Partners Announces Dates for First Quarter 2026 Earnings Release and Conference Call

MINNEAPOLIS, April 24, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced…

1 month ago

Humacyte Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess

April 24, 2026 08:00 ET  | Source: Humacyte, Inc - Ex-U.S. rights realigned under amendment to distribution agreement with Fresenius…

1 month ago

Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy

AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”), a clinical-stage biopharmaceutical company…

1 month ago

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 24, 2026 08:00 ET  | Source: Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Aligos…

1 month ago